- Home
- IMOS vs BBNX Comparison
IMOS vs BBNX Comparison
Compare IMOS & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMOS | BBNX |
|---|---|---|
| Founded | 1997 | 2015 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | IMOS | BBNX |
|---|---|---|
| Price | $41.77 | $14.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $29.08 |
| AVG Volume (30 Days) | 37.8K | ★ 1.4M |
| Earning Date | 02-24-2026 | 02-17-2026 |
| Dividend Yield | ★ 1.49% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $748,307,671.00 | $88,570,000.00 |
| Revenue This Year | $5.78 | $53.58 |
| Revenue Next Year | $10.84 | $35.12 |
| P/E Ratio | $194.47 | ★ N/A |
| Revenue Growth | N/A | ★ 67.01 |
| 52 Week Low | $12.78 | $8.89 |
| 52 Week High | $45.43 | $32.71 |
Technical Indicators
Market Signals| Indicator | IMOS | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 69.53 | 23.67 |
| Support Level | $41.35 | $14.46 |
| Resistance Level | $42.92 | $19.03 |
| Average True Range (ATR) | 1.04 | 1.65 |
| MACD | 0.20 | -0.59 |
| Stochastic Oscillator | 72.45 | 1.52 |
Price Performance
Historical ComparisonAbout IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.